Clinical Trials Directory

Trials / Completed

CompletedNCT04137302

Administration of Hydrocortisone in Young Healthy Male Volunteers

Administration of Hydrocortisone in Young Healthy Male Volunteers: Determination of Biomarkers for Distinguishing Between Local and Systemic Pathways

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Centre Hospitalier Régional d'Orléans · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The misuse of cortisone or hydrocortisone for doping purpose in sport has been widely reported in the literature, but to date, no formal testing procedure is available and applicable in an anti-doping laboratory to detect hydrocortisone doping abuse , i.e., administration by systemic way. The investigators therefore propose to identify biomarkers that clearly distinguish between an authorized local administration of hydrocortisone and a prohibited systemic administration, by studying the impact of 5-day administration of hydrocortisone per 2 different routes.

Detailed description

Clinical research with two groups of ten volunteers one group with 5 days with local administration (cream, applied to healthy skin) one group with 5 days with systemic route of administration (per os)

Conditions

Interventions

TypeNameDescription
DRUGHydrocortisone administrationHydrocortisone administration with collection of blood, urine and saliva samples before (1 week), during (5 days) and after (1 week) the 2 treatments

Timeline

Start date
2019-11-13
Primary completion
2020-01-31
Completion
2020-01-31
First posted
2019-10-24
Last updated
2020-12-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04137302. Inclusion in this directory is not an endorsement.